About Richard Meyer

Passionate, award-winning Marketing and Media Executive with an MBA and 15+ years success implementing cutting-edge strategies. Career highlights include driving development/launch of a groundbreaking e-Marketing branding initiative for Eli Lilly product Cialis that led to Website becoming #1 online pharma destination (and #1 in prescription conversions), increasing leads 30% and ROI 38% for $1B manufacturer Medtronic

How is Pfizer employee morale?

  • 41 of Pfizer’s drugs have been picked for a price hike on January 15, averaging 5%.
  • Pfizer noted Friday that the increases will be offset by higher rebates and discounts offered to insurance companies and pharmacy benefit managers.
  • Pfizer had the highest profit total ($4.1 billion) of any publicly traded health care company in the third quarter.

Continue reading

How to screw up a clinical trial

  • Amarin’s clinical trial of fish oil may be tainted because of suspicions that the placebo group received mineral oil which could affect the absorption of statins. This “anti-statin” effect could raise “bad cholesterol” levels, enhancing the separation of major adverse cardiac events (MACE) between Vascepa and control.
  • Cardiologists who reviewed the data see a big problem with the study that could mean that it exaggerates Vascepa’s benefits.
  • Mineral oil may not not behaved as a placebo at all.
  • Will insurers recommend OTC fish oil?

Continue reading

Online health seekers don’t trust social media

  • A new survey profiling how American adults’ access, use and feels about health-related information finds that most American social media users who regularly seek health information are concerned about incorrect or misleading medical information on social media, and few have found health information on social media to be accurate.
  • Two-thirds of American Healthcare Information Seekers (67 percent) report that they see health information on social media. The types of information they see on social media are mostly wellness advice (56 percent) and advertisements for treatments or medications (52 percent).
  • More than eight in 10 Healthcare Information Seekers who have seen health information on social media (83 percent) say they are concerned about incorrect or misleading medical information.
  • The youngest cohort in our study, Gen Z, is just as likely to be concerned about incorrect or misleading information as the much older Boomer generation (91 percent and 87 percent, respectively).

Continue reading

Oncology DTC

  • In 2018, the National Cancer Institute estimates there will be 1,735,000 new cases of cancer diagnosed in the U.S.
  • During the past 12 months, health care ads have reached 75% of U.S. cancer survivors on television, 54% at doctor’s offices and 40% via magazines.
  • When asked what sources of information they value the most, it’s no surprise that all survivors look primarily to their medical support team (doctors, nurses, pharmacists), medication packaging/labels and family/friends.

Continue reading

Ten companies controlled half of the health care industry’s $50 billion of global profits 9 of those 10 companies at the top are pharma firms

  • Americans spend a lot more money on hospital and physician care than prescription drugs, but pharmaceutical companies pocket a lot more of than other parts of the industry. (Source: Axios)
  • 63% of the profit total went to drug companies, even though they collected 23% of the revenue
  • Pfizer had the highest profit total ($4.1 billion) of any publicly traded health care company in the third quarter.
  • Of the 19 companies that tallied at least $1 billion of third-quarter profit, 14 were drug companies.

Continue reading

Change is going to be forced on big pharma

  • Republicans have indicated that they are willing to work with democrats on drug pricing initiatives.
  • Drug companies are focusing lobbying efforts to use a possible lame-duck session of Congress to peel back a legislative loss they suffered earlier this year.
  • Pharma is making a lobbying push to roll back seniors’ drug discounts at a time when they are reporting near record profits.
  • So far in 2018, PhRMA spent more than $20 million, according to the Center for Responsive Politics, and was the third-largest spender.

Continue reading